Par Drugs and Chemicals Limited (NSE:PAR)

Par Drugs and Chemicals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	363.62	418.43	275.77	366.54	222.43	162.06
Cash & Short-Term Investments	363.62	418.43	275.77	366.54	222.43	162.06
Cash Growth	7.40%	51.73%	-24.76%	64.79%	37.25%	-23.42%
Accounts Receivable	229.54	120.28	167.14	137.14	169.69	184.67
Other Receivables	-	-	-	-	-	0.74
Receivables	230.68	121.39	168.13	138.09	170.45	185.91
Inventory	50.4	55.97	61.94	44.21	59.68	54.98
Prepaid Expenses	-	-	0.33	0.37	0.43	0.48
Other Current Assets	26.45	47.48	42.44	47.02	41.38	32.2
Total Current Assets	671.15	643.26	548.61	596.24	494.37	435.64
Property, Plant & Equipment	362.83	371.56	389.15	413.35	386.95	343.51
Long-Term Investments	347.4	271.36	250.7	0.12	0.1	0.1
Other Long-Term Assets	5.96	5.95	5.44	6.41	7.26	7.65
Total Assets	1,387	1,292	1,194	1,016	888.68	786.9

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	119.95	81.94	108.91	53.56	80.92	106.62
Accrued Expenses	25.95	4.83	6.28	21	20.4	8.41
Current Income Taxes Payable	-	45.29	45.25	49.76	37.95	33.45
Current Unearned Revenue	-	5.36	5.23	0.05	0.62	0.09
Other Current Liabilities	15.12	0.02	0.02	0.02	0	0
Total Current Liabilities	161.01	137.44	165.69	124.39	139.89	148.57
Pension & Post-Retirement Benefits	0.63	2.4	2.67	-	1.4	4.06
Long-Term Deferred Tax Liabilities	32.44	32.44	35.8	35.4	35	35.5
Other Long-Term Liabilities	-	-	0	-	-	-
Total Liabilities	194.08	172.28	204.15	159.79	176.3	188.13

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	123.05	123.05	123.05	123.05	123.05	123.05
Additional Paid-In Capital	-	106.73	106.73	106.73	106.73	106.73
Retained Earnings	-	889.39	759.29	625.86	481.93	368.31
Comprehensive Income & Other	1,070	0.69	0.69	0.69	0.69	0.69
Total Common Equity	1,193	1,120	989.75	856.32	712.38	598.77
Shareholders' Equity	1,193	1,120	989.75	856.32	712.38	598.77
Total Liabilities & Equity	1,387	1,292	1,194	1,016	888.68	786.9

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Cash (Debt)	363.62	418.43	275.77	366.54	222.43	162.06
Net Cash Growth	7.40%	51.73%	-24.76%	64.79%	37.25%	26.19%
Net Cash Per Share	29.56	34.01	22.41	29.79	18.08	13.17
Filing Date Shares Outstanding	12.28	12.3	12.3	12.3	12.3	12.3
Total Common Shares Outstanding	12.28	12.3	12.3	12.3	12.3	12.3
Working Capital	510.13	505.82	382.93	471.84	354.48	287.07
Book Value Per Share	97.17	91.01	80.44	69.59	57.90	48.66
Tangible Book Value	1,193	1,120	989.75	856.32	712.38	598.77
Tangible Book Value Per Share	97.17	91.01	80.44	69.59	57.90	48.66
Land	-	31.48	31.48	31.48	6.21	3.32
Buildings	-	205.11	202.81	198.21	183.18	152.36
Machinery	-	467.85	463.15	459.94	443.59	413.09
Construction In Progress	-	7.17	-	0.25	2.45	2.48

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error